恒瑞医药:富马酸泰吉利定注射液获临床试验批准

南方财经网
Nov 17, 2025

  南财智讯11月17日电,恒瑞医药公告,富马酸泰吉利定注射液收到国家药品监督管理局核准签发的《药物临床试验批准通知书》,同意该药品开展用于重症监护患者机械通气时的镇痛的临床试验。富马酸泰吉利定注射液是μ阿片受体(MOR)偏向性小分子激动剂,截至目前相关项目累计研发投入约19,999万元。

(文章来源:南方财经网)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10